WASHINGTON, D.C. – June 1, 2022 – Global law firm Greenberg Traurig, LLP Shareholders James C. Fraser and Ginger Pigott will serve as panelists at the 2022 Food and Drug Law Institute (FDLI) Annual Conference: Exploring Advanced Topics in Food and Drug Law in Washington, D.C. June 15. The conference addresses complex legal, compliance, policy, and regulatory issues in many facets of the U.S. Food and Drug Administration (FDA)-related industry.
Fraser will speak on “Trends and Risks in Medical Device Enforcement and Litigation,” which session will explore the increase in FDA enforcement actions, including resources to carry out these actions. Panelists will also address areas of focus for government enforcement and litigation, including COVID-19 and laboratory testing, and legal theories being utilized.
Pigott’s panel, “Top Cases in Food and Drug Law,” will discuss significant current and future litigation.
Fraser, a former associate chief counsel at the FDA, represents and advises pharmaceutical companies, medical device companies, and other industry clients in FDA-related regulatory, compliance, and enforcement matters. He also represents pharmaceutical and medical device companies in mass tort and other product liability litigation. Fraser’s litigation work at FDA included defending the agency against Administrative Procedure Act challenges to FDA’s decisions regarding FDA-regulated products, bringing civil enforcement actions against FDA-regulated companies for violations of the Food, Drug, and Cosmetic Act, and drafting amicus curiae and other filings advocating FDA’s positions on federal preemption and preclusion. Fraser also has over 12 years of private practice experience defending pharmaceutical and medical device manufacturers in products liability and mass tort litigation throughout the United States.
Pigott provides critical product liability advice and litigation defense to emerging and established businesses. As a shareholder in the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice, she manages products liability litigation matters with an emphasis on the defense of complex medical device and pharmaceutical products. Pigott handles high-stakes, single-plaintiff cases and complex litigation, including multidistrict litigation, coordinated state actions, and class actions working as both national and regional counsel. She also works with companies to reduce and eliminate litigation risk through essential assessment and review of potential product liability exposure, including helping to organize and establish more effective claims handling in pre-litigation as well as in identifying and reducing risk-producing activities and providing information to allow companies to understand triggers for potential exposure and manage such risks.
About Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Group: The Pharmaceutical, Medical Device & Health Care Litigation Group is an integral part of the firm’s 600+ attorney Litigation Practice. Led by “trial wizard” Lori G. Cohen, this team is nationally recognized for its dynamic courtroom presence, responsiveness to clients, and deep subject matter knowledge. Recent recognitions include the shortlist for Benchmark Litigation’s 2020 “Product Liability Firm of the Year”; national rankings for 2019 “Product Liability & Mass Torts” from Chambers USA Guide; and national rankings for 2019 “Product Liability, Mass Tort and Class Action Defense: Pharmaceuticals and Medical Devices” from The Legal 500 United States.
About Greenberg Traurig’s Health Care & FDA Practice: Greenberg Traurig’s multidisciplinary Health Care & FDA Practice provides strategic counsel to a diverse group of companies and other organizations, helping them to respond proactively to the rapidly changing health care marketplace. The group combines dedicated experience in health care regulatory compliance and operational matters with the firm’s capabilities in corporate & securities, finance, tax, antitrust, ERISA, commercial and governmental litigation, restructuring, intellectual property and biotechnology, in order to provide a wide range of legal services.
About Greenberg Traurig: Greenberg Traurig, LLP has more than 2400 attorneys in 43 locations in the United States, Europe, Latin America, Asia, and the Middle East. The firm, often recognized for its focus on philanthropic giving, innovation, diversity, and pro bono, reported gross revenue of over $2 Billion for FY 2021. The firm is consistently among the top firms on the Am Law 100, Am Law Global 100, NLJ 250, and Law360 (US) 400. On the debut 2022 Law360 Pulse Leaderboard, it is a Top 15 firm. Greenberg Traurig is Mansfield Rule 4.0 Certified Plus by The Diversity Lab and net carbon neutral with respect to its office energy usage. Web: www.gtlaw.com.